Articles in section Features

<< Editorial

167 articles

General >>

<< Previous

Pages 1 ..6 7 8 9 10 11 .. 17

Next >>

Paying the Right Price in Biotech Acquisitions Published: 1 Oct-2006
By: Business Review Editor
Abstract Fulltext:
Volume: 2006 Issue: 76
Therapy Focus: Wound Care Published: 1 Oct-2006
By: Business Review Editor
Abstract Fulltext:
Volume: 2006 Issue: 76
A Hostile Genzyme and AnorMED Unrest: Changing Times for the Biotech Industry Published: 1 Oct-2006
By: Business Review Editor
Abstract Fulltext:
Volume: 2006 Issue: 76
Therapy Focus: Atopic Eczema Published: 1 Sep-2006
By: Business Review Editor
Abstract Fulltext:
Volume: 2006 Issue: 75
POZEN Forgets Migraines to Collaborate with AstraZeneca Published: 1 Sep-2006
By: Business Review Editor
Abstract Fulltext:
Volume: 2006 Issue: 75
Medicure Takes Over US Marketing of Aggrastat#174; Published: 1 Sep-2006
By: Business Review Editor
Abstract Fulltext:
Volume: 2006 Issue: 75
Biopharmaceutical Clusters in Europe: Differences and Similarities Published: 1 Sep-2006
By: Business Review Editor
Abstract Fulltext:
Volume: 2006 Issue: 75
Medivir Refocuses its Pipeline via Tibotec Deals Published: 1 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Volume: 2006 Issue: 74
Diagnosing Change: Celera Genomics' Strategic Drug Sell-Off Published: 1 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Volume: 2006 Issue: 74
Deal Making Review: 2000-2005, with Projections for 2006 Published: 1 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Volume: 2006 Issue: 74

Login

Username:

Password:

Keep me logged in